• ECCRT enters into an agreement with Qualitis for continuous online development of its staff

    Wednesday March 25th 2020

  • eTheRNA launches an international consortium and starts development of cross-strain protective CoV-2 mRNA vaccine for high risk populations

    Tuesday March 24th 2020

  • Bone Therapeutics receives Clinical Trial Application (CTA) approval for next clinical studies of its two lead candidates.

    Tuesday March 24th 2020

  • Dr. Matthias Friebe joins Camel-IDS as acting Chief Technology Officer.

    Tuesday March 24th 2020

  • ElmediX wil coronavirus stoppen door patiënten gecontroleerd op te warmen.

    Monday March 23rd 2020

  • ViroVet to support COVID19 research and sample testing

    Monday March 23rd 2020

  • Janssen start productie van desinfecterende handvloeistof om ziekenhuistekorten aan te vullen in de strijd tegen het coronavirus

    Monday March 23rd 2020

  • Alzheimer risk genes converge on microglia

    Thursday March 19th 2020

  • Your news here?

  • Een ontstekingsremmend proteïne

    Wednesday March 18th 2020

  • ImmunXperts acquired by Nexelis (Canada)

    Thursday March 5th 2020

  • Biocartis kondigt nieuw immuno-oncologie project aan met Bristol-Myers Squibb voor de registratie van de Idylla™ MSI test in China

    Thursday March 5th 2020


Strategic Partners